{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-004031","form_type":"8-K","ticker":"NTRB","cik":"0001676047","company_name":"NutriBand Inc.","filed_at":"2022-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.765175+00:00","generated_at":"2026-06-27T15:00:22.384521+00:00","sec_items":["5.02","5.03","5.07","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nutriband expands AVERSA abuse-deterrent pipeline to include buprenorphine and methylphenidate","bullets":["Adds AVERSA buprenorphine and AVERSA methylphenidate (ADHD) to pipeline; lead product AVERSA Fentanyl has $80-200M potential US sales.","CEO Gareth Sheridan and President Serguei Melnik sign 3-year employment agreements at $250k base salary; CFO Gerald Goodman at $210k.","Board grants stock options: Sheridan and Melnik each receive 20,000 shares at $5.34; 13 others get options at $4.85 or $5.34.","Irina Gram-Contulescu elected as new director; annual meeting also ratified auditor Sadler Gibb and approved 2021 Stock Option Plan.","By-laws amended to create CEO role and extend annual meeting window from 6 to 12 months after fiscal year-end."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-004031","json":"https://secwatch.observer/filing/0001213900-22-004031.json","markdown":"https://secwatch.observer/filing/0001213900-22-004031.md","text":"https://secwatch.observer/filing/0001213900-22-004031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/0001213900-22-004031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/ea154565-8k_nutriband.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T15:00:22.384521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b627524765","claim":"Irina Gram-Contulescu was elected as Director at NutriBand Inc..","evidence_excerpt":"Irina Gram-Contulescu, 34, was elected as a director of the Company at the January 21, 2022 stockholders meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/0001213900-22-004031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d304ebac7b","claim":"Serguei Melnik was appointed as Chairman of the Board at NutriBand Inc..","evidence_excerpt":"Serguei Melnik, a Board member, President and Secretary of the Company, was also appointed Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/0001213900-22-004031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}